Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;53(6):4238-4246.
doi: 10.1007/s12035-015-9341-9. Epub 2015 Jul 30.

Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?

Cuicui Li  1 , Chenglin Zhou  2 , Rena Li  3   4   5
Affiliations
Review

Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?

Cuicui Li et al. Mol Neurobiol. 2016 Aug.

Abstract

Aromatase inhibitors (AIs) have been commonly used as an effective adjuvant therapy in treatment of breast cancer, especially for menopausal women with estrogen receptor-positive breast cancer. Due to the nature of aromatase, the key enzyme for endogenous estrogen synthesis, inhibitory of aromatase-induced side effects, such as cognitive impairment has been reported in both human and animal studies. While extensive evidence suggested that physical exercises can improve learning and memory activity and even prevent age-related cognitive decline, basic research revealed some common pathways between exercise and estrogen signaling that affected cognitive function. This review draws on clinical and basic studies to assess the potential impact of exercise in cognitive function from women treated with AIs for breast cancer and explore the potential mechanism and effects of exercise on estrogen-related cognition.

Keywords: Aromatase inhibitors; Breast cancer; Cognition; Exercise.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. The relationship of mechanisms between exercise- and estrogen- induced neuroprotection
Exercise can facilitate neuroplasticity and neurogenesis through improving the expression of VEGF, IGF-1, BDNF as indicated as red lines, while the effects of estrogen on cognitive function might be mediated through estrogen receptors and regulate VEGF, IGF-1 and BDNF to exert neuroprotective functions as shown in blue lines.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Boon WC, Chow JDY, Simpson ER. The Multiple Roles of Estrogens and the Enzyme Aromatase. Progress in brain research. 2010;181:209–232. doi: 10.1016/s0079-6123(08)81012-6. - DOI - PubMed
    1. Janicki SC, Park N, Cheng R, Schupf N, Clark LN, Lee JH. Aromatase variants modify risk for Alzheimer’s disease in a multiethnic female cohort. Dementia and geriatric cognitive disorders. 2013;35(5–6):340–346. doi: 10.1159/000343074. - DOI - PMC - PubMed
    1. Medway C, Combarros O, Cortina-Borja M, Butler HT, Ibrahim-Verbaas CA, de Bruijn RF, Koudstaal PJ, van Duijn CM, Ikram MA, Mateo I, Sanchez-Juan P, Lehmann MG, Heun R, Kolsch H, Deloukas P, Hammond N, Coto E, Alvarez V, Kehoe PG, Barber R, Wilcock GK, Brown K, Belbin O, Warden DR, Smith AD, Morgan K, Lehmann DJ. The sex-specific associations of the aromatase gene with Alzheimer’s disease and its interaction with IL10 in the Epistasis Project. European journal of human genetics: EJHG. 2014;22(2):216–220. doi: 10.1038/ejhg.2013.116. - DOI - PMC - PubMed
    1. Bian C, Zhao Y, Guo Q, Xiong Y, Cai W, Zhang J. Aromatase inhibitor letrozole downregulates steroid receptor coactivator-1 in specific brain regions that primarily related to memory, neuroendocrine and integration. The Journal of steroid biochemistry and molecular biology. 2014;141:37–43. doi: 10.1016/j.jsbmb.2013.12.020. - DOI - PubMed
    1. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer’s disease animal model. Proceedings of the National Academy of Sciences of the United States of America. 2005;102(52):19198–19203. doi: 10.1073/pnas.0505203102. - DOI - PMC - PubMed

Publication types